Joint Venture26 Jul 2025, 06:45 pm
Shukra Pharmaceuticals Ltd. Executes Agreement with APITCO Limited on 25th July 2025
AI Summary
Shukra Pharmaceuticals Ltd. has executed an agreement with APITCO Limited on 25th July 2025. The purpose of the agreement is to collaborate on various healthcare government assignments across sectors, leveraging APITCO's expertise as a PSU and Shukra's capabilities in healthcare project management, services, and training. The collaboration aims to contribute to national-level developmental, industrial, and consulting initiatives. All projects undertaken through this collaboration will be executed under defined Service Level Agreements (SLAs) with detailed scope, timelines, deliverables, and performance standards.
Key Highlights
- Shukra Pharmaceuticals Ltd. and APITCO Limited entered into an agreement on 25th July 2025
- The purpose of the agreement is to collaborate on various healthcare government assignments across sectors
- The collaboration aims to contribute to national-level developmental, industrial, and consulting initiatives
- All projects will be executed under defined Service Level Agreements (SLAs) with detailed scope, timelines, deliverables, and performance standards
- Shukra Pharmaceuticals Ltd. and APITCO Limited are not shareholders in each other's entities